Cargando…

Immunotherapy for Pediatric Brain Tumors

Malignant brain tumors are the most common cause of solid cancer death in children. New targeted therapies are vital to improve treatment outcomes, but must be developed to enable trafficking across the blood brain barrier (BBB). Since activated T cells cross the BBB, cancer immunotherapy can be har...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayour, Elias J., Mitchell, Duane A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664064/ https://www.ncbi.nlm.nih.gov/pubmed/29065490 http://dx.doi.org/10.3390/brainsci7100137

Ejemplares similares

Emerging trends in immunotherapy for pediatric sarcomas
por: Dyson, Kyle A., et al.
Publicado: (2019)

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018)

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
por: Sayour, Elias J, et al.
Publicado: (2015)

2422: Magnetic nanoparticles facilitate tracking of dendritic cells for treatment of malignant brain tumors
por: Grippin, Adam, et al.
Publicado: (2018)

Manipulation of Innate and Adaptive Immunity through Cancer Vaccines
por: Sayour, Elias J., et al.
Publicado: (2017)

Translational nanoparticle engineering for cancer vaccines
por: Grippin, Adam J., et al.
Publicado: (2017)

Contemporary RNA Therapeutics for Glioblastoma
por: Melnick, Kaitlyn, et al.
Publicado: (2021)

Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy
por: Dastmalchi, Farhad, et al.
Publicado: (2021)

IMMU-13. CUSTOMIZABLE MULTI-LAMELLAR RNA-NANOPARTICLES FOR PEDIATRIC GLIOMA
por: Mendez-Gomez, Hector, et al.
Publicado: (2021)

Microglia in pediatric brain tumors: The missing link to successful immunotherapy
por: du Chatinier, Aimée, et al.
Publicado: (2023)

Immunotherapy for the treatment of pediatric brain tumors: a narrative review
por: Shalita, Chidyaonga, et al.
Publicado: (2022)

Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
por: Foster, Jessica B., et al.
Publicado: (2023)

Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic
por: Fenton, Graeme A., et al.
Publicado: (2023)

New Era of Immunotherapy in Pediatric Brain Tumors: Chimeric Antigen Receptor T-Cell Therapy
por: Wu, Wan-Tai, et al.
Publicado: (2021)

RNA-electroporated T cells for cancer immunotherapy
por: Pohl-Guimarães, Fernanda, et al.
Publicado: (2020)

CAR T Cell Locomotion in Solid Tumor Microenvironment
por: Nguyen, Duy T., et al.
Publicado: (2022)

Immunotherapy in Pediatric Solid Tumors—A Systematic Review
por: Marayati, Raoud, et al.
Publicado: (2019)

COVD-02. ADAPTING RNA-NANOPARTICLE VACCINES FROM GLIOBLASTOMA TO SARS-COV-2
por: Mendez-Gomez, Hector, et al.
Publicado: (2020)

Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
por: Driggers, Lara, et al.
Publicado: (2009)

The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy
por: Desland, Fiona A., et al.
Publicado: (2020)

2173 RNA-nanoparticles to enhance and track dendritic cell migration
por: Grippin, Adam J., et al.
Publicado: (2018)

Immunology of allergen immunotherapy
por: Rahman, Rifat S, et al.
Publicado: (2022)

Modern Radiotherapy for Pediatric Brain Tumors
por: DeNunzio, Nicholas J., et al.
Publicado: (2020)

Advances in the Treatment of Pediatric Brain Tumors
por: Kulubya, Edwin S., et al.
Publicado: (2022)

Optimizing T Cell-Based Therapy for Glioblastoma
por: Karachi, Aida, et al.
Publicado: (2021)

Direct imaging of RNA loaded lipid-nanoparticles’ self assembly and cellular expression for cancer immunotherapy and RNA-based vaccines
por: Ashbrook, Jewel, et al.
Publicado: (2022)

Molecular Imaging in Pediatric Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2019)

MR Imaging of Pediatric Brain Tumors
por: Jaju, Alok, et al.
Publicado: (2022)

Essential Management of Pediatric Brain Tumors
por: Lutz, Katharina, et al.
Publicado: (2022)

Approaches to Enhance Natural Killer Cell-Based Immunotherapy for Pediatric Solid Tumors
por: Quamine, Aicha E., et al.
Publicado: (2021)

Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling
por: Dastmalchi, Farhad, et al.
Publicado: (2019)

Suppressing immunotherapy by organ-specific tumor microenvironments: what is in the brain?
por: Zhang, Chenyu, et al.
Publicado: (2019)

Tumor-Treating Fields Therapy for Pediatric Brain Tumors
por: Makimoto, Atsushi, et al.
Publicado: (2021)

Advanced Neuroimaging Approaches to Pediatric Brain Tumors
por: Nikam, Rahul M., et al.
Publicado: (2022)

Adoptive Immunotherapy and High-Risk Myeloma
por: Duane, Catherine, et al.
Publicado: (2023)

The Growing Relevance of Immunoregulation in Pediatric Brain Tumors
por: Melcher, Viktoria, et al.
Publicado: (2021)

Evaluation of phase I clinical trial designs for combinational agents along with guidance based on simulation studies
por: Wang, Shu, et al.
Publicado: (2022)

Steroid utility, immunotherapy, and brain tumor management: an update on conflicting therapies
por: Goldman, Matthew, et al.
Publicado: (2022)

PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors
por: Lichtor, Terry, et al.
Publicado: (2008)

Neurocognitive and Psychosocial Outcomes in Pediatric Brain Tumor Survivors
por: Stavinoha, Peter L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9p7s9sk0d7cq4pjid8mq012bpb